VAQTA 25 [iU]/.5mL (hepatitis A vaccine, inactivated INJECTION, SUSPENSION) 25 [iU]/.5mL

VAQTA 25 [iU]/.5mL is an inactivated hepatitis A vaccine designed to prevent hepatitis A virus infection. This intramuscular injection is suitable for individuals seeking protection against hepatitis A, a viral liver disease.

Strength

25 [iU]/.5mL

Pack Size

10 VIAL, SINGLE-DOSE in 1 CARTON (0006-4831-41) / .5 mL in 1 VIAL, SINGLE-DOSE (0006-4831-01)

Manufacturer / TM Owner

Merck Sharp & Dohme LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

VAQTA 25 [iU]/.5mL is primarily used for the prevention of hepatitis A, a contagious liver infection caused by the hepatitis A virus. This vaccine is often recommended for individuals who are at higher risk of exposure, such as travelers to regions with high rates of hepatitis A, as well as for those with certain medical conditions or lifestyle factors that increase their risk. The vaccine works by stimulating the body's immune system to produce antibodies against the hepatitis A virus, providing long-lasting protection.

Side Effects

Common effects of VAQTA 25 [iU]/.5mL may include mild soreness, redness, or swelling at the injection site. Some individuals might experience temporary fatigue, headache, or low-grade fever following vaccination. These effects are generally mild and short-lived, resolving on their own within a few days.

Precautions & Warnings

VAQTA 25 [iU]/.5mL should be administered by a healthcare professional. Individuals with a history of severe allergic reactions to any component of the vaccine, including neomycin, should avoid this vaccine. It is important to inform your healthcare provider about any current illnesses or allergies before receiving the vaccine.

Avoid Interactions

VAQTA 25 [iU]/.5mL may interact with certain medications or other vaccines. It is advisable to discuss your current medication regimen with a healthcare provider before receiving this vaccine. Additionally, individuals who are immunocompromised or taking immunosuppressive therapies should consult their healthcare provider for personalized advice.

Frequently Asked Questions

VAQTA 25 [iU]/.5mL is used to prevent hepatitis A virus infection, particularly in individuals at higher risk of exposure.

VAQTA 25 [iU]/.5mL is administered as an intramuscular injection, typically in the upper arm.

Common side effects may include mild soreness, redness, or swelling at the injection site, as well as temporary fatigue or headache.

Individuals with a history of severe allergic reactions to any component of the vaccine, including neomycin, should avoid VAQTA 25 [iU]/.5mL.

It is advisable to discuss your current medication regimen with a healthcare provider before receiving VAQTA 25 [iU]/.5mL to avoid potential interactions.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.